Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections have transformed weight loss treatment for millions, but injection technique directly affects how well the medication works. One common mistake—using the same injection site repeatedly—can lead to lipohypertrophy, a condition where fatty tissue accumulates beneath the skin, compromising both drug delivery and patient comfort.

What Is Lipohypertrophy and How Does It Develop

Lipohypertrophy occurs when repeated injections into the same area trigger local inflammation and abnormal fat cell growth. The body responds to chronic needle trauma by depositing extra adipose tissue, creating firm, enlarged bumps under the skin. This thickened layer acts as a barrier, slowing medication absorption and reducing clinical efficacy over time.

Research on insulin injection practices—which share similar mechanics with GLP-1 therapy—shows that 50% of patients who rotate sites inconsistently experience some degree of lipohypertrophy. The condition is painless initially, which means many patients discover it only when their weight loss plateaus or side effects diminish. PlexusDx compounded semaglutide injections deliver consistent potency when administered correctly, making proper technique a critical success factor.

Why Site Rotation Matters for Semaglutide Absorption

Subcutaneous injections rely on consistent blood flow and healthy tissue architecture to transport medication into the bloodstream. When lipohypertrophy develops, blood vessels become compressed and surrounding tissue loses elasticity, creating a dead zone where drug absorption becomes unpredictable. Rotating injection sites maintains normal tissue integrity and ensures each dose reaches systemic circulation at the intended rate.

Healthcare providers recommend spacing injection sites at least one inch apart and rotating between upper arms, thighs, and abdomen across weekly doses. This distance allows treated areas to recover and prevents cumulative tissue damage. PlexusDx patients receive detailed injection guidance with their first shipment, emphasizing that consistent absorption directly correlates with steady, sustainable weight loss results.

How to Identify Lipohypertrophy and Prevent It

Early warning signs include visible lumps, dimpling, or hardened areas at injection sites that persist for more than one week. Some patients describe the sensation as bumpy or corded skin, though lipohypertrophy itself is not painful. Preventing lipohypertrophy requires a documented rotation schedule—many patients use a simple chart or phone reminder to track which body area received the previous injection.

If lipohypertrophy has already developed, switching to completely different injection sites can allow existing lesions to gradually resolve over 2–4 weeks, though established bumps may take longer to fully flatten. Avoiding the affected area entirely gives inflammation time to subside. PlexusDx recommends consulting with your prescribing provider if you notice persistent injection-site changes, as they can adjust technique or monitor absorption effectiveness through regular check-ins.

PlexusDx Compounded Semaglutide and Injection Best Practices

PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity that maximizes therapeutic benefit when properly injected. The potency of the medication depends not just on formulation quality, but on consistent subcutaneous delivery into healthy tissue. Patients starting PlexusDx semaglutide injections at $149/month receive written injection technique guidance and access to clinical support for any site-related questions.

Many PlexusDx patients find that pairing compounded semaglutide with the optional Precision Peptide Genetic Test ($99 add-on after the first month) provides personalized insights into individual peptide-pathway responsiveness. Understanding how your body metabolizes GLP-1 receptor signaling can help your provider optimize dosing schedules and anticipate absorption patterns. Proper injection technique combined with genetic-informed dosing creates the foundation for durable, effective weight loss outcomes.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can repeated injections in the same spot permanently damage the skin?

Lipohypertrophy is usually reversible if site rotation begins promptly. Once you switch to unused injection areas, the bumpy tissue gradually softens and flattens over 2–4 weeks as inflammation resolves. Permanent scarring is rare unless the area develops severe infection, which is prevented through proper sterile technique and rotation.

How many different injection sites do I need to maintain safe rotation?

Healthcare providers recommend maintaining at least four distinct zones: both upper arms, both thighs, or abdomen. Rotating weekly across these areas ensures each site recovers between injections. Even simply alternating left and right sides of the same body area (like left versus right thigh) significantly reduces lipohypertrophy risk compared to single-site dosing.

Does lipohypertrophy affect how much weight I'll lose on semaglutide?

Yes—poor absorption from lipohypertrophic tissue can reduce semaglutide's appetite-suppressing effects and slow weight loss progress. PlexusDx compounded semaglutide starting at $149/month delivers consistent quality, but injection technique determines how effectively your body utilizes each dose. Proper site rotation ensures predictable medication delivery and maximum therapeutic impact.

What if I've already developed lipohypertrophy from previous treatment?

Stop injecting into affected areas immediately and switch to untouched sites across arms, thighs, and abdomen. Most lipohypertrophy resolves within a few weeks once the area rests. If bumps persist beyond four weeks or worsen, contact your prescribing provider to rule out infection or other complications.

How does the Precision Peptide Genetic Test help with semaglutide treatment?

PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes 14 pathways and 49 peptides, including GLP1R variants that influence individual medication response. Understanding your genetic predisposition to GLP-1 sensitivity helps your provider anticipate absorption patterns and optimize dosing timing around injection-site healing, supporting better overall outcomes alongside proper rotation technique.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves